Severe acute respiratory syndrome treatment: Present status and future strategy

Current Opinion in Investigational Drugs

Volumn 4, Issue 8, 2003, Pages 918-920

  Lau, Arthur Chun Wing ^a   So, Loletta Kit Ying ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; CHINESE DRUG; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; GLUCOCORTICOID; GLYCYRRHIZIC ACID; IMMUNOGLOBULIN G; IMMUNOMODULATING AGENT; INFLIXIMAB; INTERFERON; LACTATE DEHYDROGENASE; LOPINAVIR PLUS RITONAVIR; METHYLPREDNISOLONE; OSELTAMIVIR; PENTOXIFYLLINE; PROTEINASE INHIBITOR; RIBAVIRIN; THYMOSIN ALPHA1; VIRUS PROTEIN; VIRUS VACCINE;

ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CHINESE MEDICINE; CLINICAL TRIAL; CORONAVIRUS; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG ABSORPTION; DRUG MEGADOSE; EDITORIAL; ENZYME BLOOD LEVEL; HUMAN; IMMUNE DEFICIENCY; IN VITRO STUDY; LOW DRUG DOSE; LUNG FIBROSIS; LUNG INJURY; NONHUMAN; PNEUMONIA; SEVERE ACUTE RESPIRATORY SYNDROME; SIDE EFFECT; THORAX RADIOGRAPHY; VACCINATION; VIRUS LOAD; VIRUS REPLICATION;

ADJUVANTS, IMMUNOLOGIC; ANTIVIRAL AGENTS; DISEASE OUTBREAKS; HUMANS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 0141719646     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (25)

1. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE et al.: A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 348(20):1953-1966.
2. Drosten C, Günther S, Preiser W, Van Der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RAM, Berger A. et al: Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 348(20):1967-1976.
3. Peiris JSM, Lai ST, Poon LLM, Guan Y, Yam LYC, Lim W, Nicholls J, Yee WKS, Yan WW, Cheung MT, Cheng VCC et al: Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet (2003) 361(9366):1319-1325.
4. Cumulative number of reported probable cases of SARS. From 1 Nov 2002 to 11 July 2003: World Health Organization (2003). http://www.who.int/csr/sars/country/2003_07_11/en/
5. Cyranoski D, Abbott A: Virus detectives seek source of SARS in China's wild animals. Nature (2003) 423(6939):467.
6. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med (2001) 163(7):1730-1754.
7. Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL, Mazzulli T, Avendano M, Derkach P, Ephtimios IE et al: Clinical features and short-term outcomes of 144 patients with SARS in the Greater Toronto area. J Am Med Assoc (2003) 289(21):2801-2809.
8. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, Ahuja A, Yung MY, Leung CB, To KF, Lui SF et al: A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med (2003) 348(20):1986-1994.
9. Peiris JSM, Chu CM, Cheng VCC, Chan KS, Hung IFN, Poon LLM, Law KI, Tang BSF, Hon TYW, Chan CS, Chan KH et al: Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. Lancet (2003) 361(9371):1767-1772.
10. So LKY, Lau ACW, Yam LYC, Cheung TMT, Poon E, Yung RWH, Yuen KY: Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet (2003) 361(9369):1615-1617.
11. Cyranoski D: Critics slam treatment for SARS as ineffective and perhaps dangerous. Nature (2003) 423(6935):4.
12. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW: Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet (2003) 361(9674):2045-2046.
13. Ning Q, Brown D, Parodo J, Cattral M, Goryczynski R, Cole E, Fung L, Ding JW, Liu MF, Rotstein O, Phillips MJ et al.: Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol (1998) 160(7):3487-3493.
14. Hultgren C, Milich DR, Weiland O, Sällberg M: The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J Gen Virol (1998) 79(10):2381-2391.
15. Sung J: Clinical diagnosis and management of SARS. WHO Global Conference on Severe Acute Respiratory Syndrome (SARS), Kuala Lumpur, Malaysia (2003).
16. Zhong NS, Zeng GQ: Our strategies for fighting severe acute respiratory syndrome (SARS). Am J Respir Crit Care Med (2003) 168(1):7-9.
17. Holmes KV: SARS coronavirus: A new challenge for prevention and therapy. J Clin Invest (2003) 111(11):1605-1609.
18. pro) structure: Basis for design of anti-SARS drugs. Science (2003) 300(5626):1763-1767.
19. Meduri GU, Chrousos GP: Duration of glucocorticoid treatment and outcome in sepsis: Is the right drug used the wrong way? Chest (1998) 114(2):355-360.
20. Kamps BS, Hoffmann C: SARS Reference, 2nd Edition, Flying Publisher, Germany (2003):43-54 http://sarsreference.com
21. Zhao Z, Zhang F, Xu M, Huang K, Zhong W, Cai W, Yin Z, Huang S, Deng Z, Wei M, Xiong J et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol (2003) 52(8):715-720.
22. Clinical and scientific work. Convalescent serum therapy: The Chinese Universiry of Hong Kong, Hong Kong SAR, China (2003). http://www.cuhk.edu.hk/sars_care/c2_016.htm
23. Wong VWS, Dai D, Wu AKL, Sung JYY: Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J (2003) 9(3):199-201.
24. Gao ZC, Zhu JH, Sun Y, Ding XL, Ma JS, Cui YX, Du XK, Gao T, He QY: Clinical investigation of outbreak of nosocomial severe acute respiratory syndrome. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue (2003) 15(6):332-335.
25. Bermejo-Martin JF, Jimenez JL, Munoz-Fernandez A: Pentoxifylline and severe acute respiratory syndrome (SARS): A drug to be considered. Med Sci Monit (2003) 9(6):SR29-SR34.